Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Journal:

The New England Journal of Medicine

Published:

2025-06-03

DOI:

10.1056/nejmoa2502099

Affiliations:

29

Authors:

26

Go to article

Institutions	Authors	Share
Amgen, United States of America (USA)	4.000000	0.15
San Giovanni Hospital of Rome, Italy	1.000000	0.04
National Cancer Center Hospital, Japan	1.000000	0.04
The First Affiliated Hospital of Nanchang University, China	1.000000	0.04
Marlene and Stewart Greenebaum Comprehensive Cancer Center, United States of America (USA)	1.000000	0.04
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.04
NYU Laura and Isaac Perlmutter Cancer Center, United States of America (USA)	1.000000	0.04
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	1.000000	0.04
Memorial Ankara Hospital, Turkey	1.000000	0.04
Harbin Medical University Cancer Hospital, China	1.000000	0.04
National Cancer Center (NCC), South Korea	1.000000	0.04
Istanbul Medeniyet University (IMU), Turkey	1.000000	0.04
Xinqiao Hospital, Army Medical University, China	1.000000	0.04
St. Luke's Hospital, Greece	1.000000	0.04
European Interbalkan Medical Center (EIMC), Greece	1.000000	0.04
The Oncology Institute "Prof. Dr. Ion Chiricuta" (IOCN), Romania	1.000000	0.04
Xijing Hospital, China	1.000000	0.04
Yonsei Cancer Hospital, South Korea	1.000000	0.04
Samsung Medical Center (SMC), South Korea	1.000000	0.04
National Center for Tumor Diseases West (NCT West), Germany	0.500000	0.02
Toulouse University Hospital (CHU-Toulouse), France	0.500000	0.02
Université de Toulouse, France	0.500000	0.02
Essen University Hospital, Germany	0.500000	0.02
The Christie NHS Foundation Trust, United Kingdom (UK)	0.500000	0.02
The University of Manchester (UoM), United Kingdom (UK)	0.500000	0.02
Hospital Universitario 12 de Octubre, Spain	0.250000	0.01
Spanish National Cancer Research Centre (CNIO), Spain	0.250000	0.01
Complutense University of Madrid (UCM), Spain	0.250000	0.01
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain	0.250000	0.01

Interested in Oncology and Carcinogenesis?